Koninklijke Philips NV (PHG)
25.89
-0.16
(-0.61%)
USD |
NYSE |
Sep 04, 16:00
25.89
0.00 (0.00%)
After-Hours: 20:00
Koninklijke Philips Research and Development Expense (Quarterly) : 562.75M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 562.75M |
| March 31, 2026 | 460.95M |
| December 31, 2025 | 497.00M |
| September 30, 2025 | 483.81M |
| June 30, 2025 | 455.65M |
| March 31, 2025 | 480.98M |
| December 31, 2017 | 542.79M |
| September 30, 2017 | 533.70M |
| June 30, 2017 | 470.68M |
| March 31, 2017 | 554.75M |
| December 31, 2016 | 484.17M |
| September 30, 2016 | 478.76M |
| June 30, 2016 | 562.71M |
| March 31, 2016 | 518.28M |
| December 31, 2015 | 587.75M |
| September 30, 2015 | 524.63M |
| June 30, 2015 | 536.31M |
| March 31, 2015 | 483.10M |
| December 31, 2014 | 583.35M |
| September 30, 2014 | 527.54M |
| June 30, 2014 | 584.20M |
| March 31, 2014 | 575.47M |
| December 31, 2013 | 620.74M |
| September 30, 2013 | 582.68M |
| June 30, 2013 | 543.02M |
| Date | Value |
|---|---|
| March 31, 2013 | 559.81M |
| December 31, 2012 | 634.18M |
| September 30, 2012 | 555.45M |
| June 30, 2012 | 560.79M |
| March 31, 2012 | 587.48M |
| December 31, 2011 | 604.85M |
| September 30, 2011 | 549.26M |
| June 30, 2011 | 547.97M |
| March 31, 2011 | 543.66M |
| December 31, 2010 | 525.03M |
| September 30, 2010 | 477.76M |
| June 30, 2010 | 483.22M |
| March 31, 2010 | 486.08M |
| December 31, 2009 | 691.14M |
| September 30, 2009 | 531.72M |
| June 30, 2009 | 522.44M |
| March 31, 2009 | 527.35M |
| December 31, 2008 | 689.84M |
| September 30, 2008 | 666.99M |
| June 30, 2008 | 654.55M |
| March 31, 2008 | 579.51M |
| December 31, 2007 | 600.82M |
| September 30, 2007 | 565.85M |
| June 30, 2007 | 546.87M |
| March 31, 2007 | 528.07M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ResMed, Inc. | 105.73M |
| Medtronic Plc | 771.00M |
| iRhythm Holdings, Inc. | 19.84M |
| EDAP TMS SA | 2.314M |
| GE Healthcare Technologies, Inc. | 323.00M |